Xamic 500 Tablet contains Tranexamic Acid 500 mg, an antifibrinolytic agent used to reduce or prevent excessive bleeding by inhibiting the activation of plasminogen to plasmin, thereby stabilizing formed blood clots. It is indicated for the treatment and prevention of hemorrhagic conditions such as heavy menstrual bleeding (menorrhagia), oral bleeding, and bleeding associated with surgical procedures or trauma. Tranexamic Acid is also employed in managing bleeding disorders like hemophilia and in certain cases of hereditary angioedema. The tablet is administered orally, with dosage tailored according to the severity of bleeding and clinical response. Xamic 500 is contraindicated in patients with active intravascular clotting, hypersensitivity to Tranexamic Acid, or history of thromboembolic disease. Caution is advised in individuals with renal impairment, as dosage adjustment may be necessary. Common side effects are generally mild and may include gastrointestinal disturbances such as nausea, vomiting, and diarrhea. Serious adverse events are rare but may involve thromboembolic complications. Xamic 500 should be used under medical supervision, with appropriate monitoring to ensure efficacy and safety. It is essential to adhere to prescribed dosages and report any unusual symptoms promptly.